COGT icon

Cogent Biosciences
COGT

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$54
48% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
Chris Raymond
50% 1-yr COGT win rate
18 Feb ‘26 1 month ago
Wedbush
Wedbush
David Nierengarten
0% 1-yr COGT win rate
21 Jan ‘26 2 months ago